Add To Favorites In PHR
Dr. Robert A. Kloner reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. His major research interests are cardiac cell transplantation; protection of ischemic myocardium; development of therapies for limiting myocardial infarct size; cardiac function following coronary artery occlusion; the effect of toxins on the heart, including the effect of air pollution on the heart; preventive cardiology; hypertension; and PDE5 inhibition. Dr. Kloner is Vice President of Translation and Director of the Cardiovascular Research Institute at Huntington Medical Research Institutes in Pasadena, California. He is also Professor of Clinical Medicine at the Keck School of Medicine at University of Southern California in Los Angeles, California. Dr. Kloner is a frequent lecturer at major scientific symposia including the Scientific Sessions of the American Heart Association, American College of Cardiology, and Transcatheter Cardiovascular Therapeutics Meetings.
PhD: Northwestern University, Chicago, IL, 1974
MD: Northwestern University Medical School, Chicago, IL, 1975
Medical House Officer, Peter Bent Brigham Hospital, Boston, MA, 1975–1976
Clinical Fellow in Medicine: Harvard Medical School, Boston, MA, 1975–1978
Assistant Resident Physician: Peter Bent Brigham Hospital, Boston, MA, 1976–1977
Senior Resident Physician: Peter Bent Brigham Hospital, Boston, MA, 1977–1978
Chief Resident: West Roxbury Veterans Association Hospital, West Roxbury, MA, 1978
Research Fellowship in Medicine: Harvard Medical School, Boston, MA, 1978–1979
Research and Clinical Fellowship in Medicine, Cardiology: Peter Bent Brigham Hospital, 1978–1979
American Board of Internal Medicine
Cardiovascular Disease, American Board of Internal Medicine
University of Southern California Keck School of Medicine, Los Angeles, CA:
Professor of Internal Medicine, Wayne State University School of Medicine, Detroit, MI, 1985–1988
Harvard Medical School, Boston, MA:
The final approval of Healthwise content is always made by a clinician with no financial conflicts.
Dr. Kloner is on the speakers bureau for Lilly and Novartis and has served on the speakers bureau for Pfizer in the past. He is a consultant and grant recipient and is on the speakers bureau for Gilead. He has received a grant from Alavita Pharmaceuticals, Alfred Mann Institute at the Techneon, and PeriCor Therapeutics.
Current as of: January 10, 2014
Author: Healthwise Staff
To learn more about Healthwise, visit Healthwise.org.
© 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
print close directions